Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104204541 | 10420454 | 1 | I | 201402 | 20140508 | 20140701 | 20140701 | PER | 1000067212 | FOREST | 58.00 | YR | F | N | 84.82000 | KG | 20140612 | N | CN | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104204541 | 10420454 | 1 | PS | LINZESS | LINACLOTIDE | 1 | 290MCG DAILY AS NEEDED | Y | D | 202811 | |||||||||
| 104204541 | 10420454 | 3 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 5 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 7 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 9 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 11 | C | NITROGLYCERIN (GLYCERYL TRINITRATE) | 2 | 0 | |||||||||||||
| 104204541 | 10420454 | 13 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 15 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 17 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 19 | C | RANITIDINE | RANITIDINERANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 21 | C | TOPIRAMATE. | TOPIRAMATE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 23 | C | ROPINIROLE. | ROPINIROLE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 25 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 27 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 29 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 31 | C | FENTANYL. | FENTANYL | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 33 | C | HYDROCODONE/APAP (VICODIN) | 2 | 0 | |||||||||||||
| 104204541 | 10420454 | 35 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 104204541 | 10420454 | 37 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104204541 | 10420454 | 1 | Constipation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104204541 | 10420454 | Decreased appetite | |
| 104204541 | 10420454 | Dehydration | |
| 104204541 | 10420454 | Diarrhoea | |
| 104204541 | 10420454 | Nausea | |
| 104204541 | 10420454 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 104204541 | 10420454 | CSM |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104204541 | 10420454 | 1 | 201402 | 201404 | 0 |